LyondellBasell Industries N.V. Total Cost of Revenue decreased by 3.8% to $6.50B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8.9%, from $7.13B to $6.50B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows a downward trend with a -7.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.68B | $10.11B | $10.93B | $11.14B | $12.27B | $11.09B | $9.36B | $8.86B | $8.87B | $9.18B | $1.53B | $7.20B | $7.24B | $7.30B | $7.00B | $7.13B | $6.87B | $6.82B | $6.76B | $6.50B |
| QoQ Change | — | +16.5% | +8.2% | +1.8% | +10.2% | -9.6% | -15.6% | -5.3% | +0.0% | +3.5% | -83.4% | +371.8% | +0.6% | +0.8% | -4.1% | +1.8% | -3.6% | -0.7% | -1.0% | -3.8% |
| YoY Change | — | — | — | — | +41.4% | +9.7% | -14.4% | -20.4% | -27.7% | -17.2% | -83.7% | -18.8% | -18.3% | -20.4% | +358.9% | -1.0% | -5.1% | -6.6% | -3.5% | -8.9% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| O&P- EAI | — | — | — | $2.51B | $2.58B | $2.46B | $2.42B | $2.43B |
| O&P- Americas | — | — | — | $2.27B | $2.11B | $2.23B | $2.26B | $2.18B |
| I&D | — | — | — | $2.23B | $2.05B | $2.07B | $1.99B | $1.86B |
| Other | — | — | — | -$732.00M | -$749.00M | -$794.00M | -$686.00M | -$785.00M |
| APS | — | — | — | $800.00M | $807.00M | $766.00M | $701.00M | $750.00M |
| Technology | — | — | — | $44.00M | $82.00M | $79.00M | $75.00M | $60.00M |
| Refining | $2.16B | $2.16B | $2.16B | — | — | — | — | — |
| Total | $7.24B | $7.30B | $7.00B | $7.13B | $6.87B | $6.82B | $6.76B | $6.50B |
Refining is derived from annual filings.
Refining was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.